Differential effects of cAMP-elevating drugs on stimulus-induced cytosolic calcium changes in human basophils

L. M. Botana, Donald Macglashan

Research output: Contribution to journalArticle

Abstract

Drugs that elevate cAMP levels in human basophils are known to inhibit immunoglobulin E (IgE)-mediated histamine release. We have examined whether cAMP-active agents inhibit the cytosolic Ca2+, [Ca2+](i), response that normally accompanies activation of basophils. As previously described, this [Ca2+](i) response is biphasic, one phase dependent on internal sources of calcium and a second later phase dependent on extracellular calcium, as observed in many cell types. Forskolin and rolipram or their combination had no effect on the initial elevation of cytosolic calcium that follows stimulation with anti-IgE antibody. In contrast, the second phase of the IgE- mediated calcium response was inhibited by these agents. For IgE-mediated responses, the relative efficacy of various cAMP active agents (rolipram ≃ forskolin <dibutyryl cAMP <forskolin + rolipram) for the inhibition of histamine release and the second-phase calcium response was similar and roughly paralleled the measured increase in basophil cAMP. In contrast, neither the first nor the second phase of the f-Met-Leu-Phe (fMLP)-induced calcium response was inhibited by any of the cAMP-active agents tested. Indeed, at low concentrations of fMLP, a combination of forskolin and rolipram caused slight enhancement of the calcium response. This result was consistent with the observations that these agents had no effect or caused slight enhancement of histamine or leukotriene released induced by fMLP. Similarly, cAMP-active agents caused no inhibition of C5a or phorbol ester (phorbol myristate acetate)-induced histamine release. These observations suggest that inhibition of the phase of the calcium response that is dependent on extracellular calcium could account for the inhibition of histamine release by these agents. However, these studies also suggested that (1) this is effect is not exerted at the level of the inositol trisphosphate (InsP3) receptor or InsP3 metabolism and (2) the mechanisms that maintain the second-phase calcium response are possibly distinct for IgE- and fMLP- mediated reactions because cAMP-active agents inhibited the second-phase response of only one stimulus.

Original languageEnglish (US)
Pages (from-to)798-804
Number of pages7
JournalJournal of Leukocyte Biology
Volume55
Issue number6
StatePublished - 1994

Fingerprint

Basophils
Calcium
methionyl-leucyl-phenylalanine
Rolipram
Pharmaceutical Preparations
Immunoglobulin E
Histamine Release
Colforsin
Histamine Agents
Leukotrienes
Phorbol Esters
Tetradecanoylphorbol Acetate
Inositol
Histamine

Keywords

  • anti-IgE
  • basophils
  • calcium
  • cAMP
  • fMLP

ASJC Scopus subject areas

  • Cell Biology

Cite this

Differential effects of cAMP-elevating drugs on stimulus-induced cytosolic calcium changes in human basophils. / Botana, L. M.; Macglashan, Donald.

In: Journal of Leukocyte Biology, Vol. 55, No. 6, 1994, p. 798-804.

Research output: Contribution to journalArticle

@article{c785f5d898924cab92df7daf55a28781,
title = "Differential effects of cAMP-elevating drugs on stimulus-induced cytosolic calcium changes in human basophils",
abstract = "Drugs that elevate cAMP levels in human basophils are known to inhibit immunoglobulin E (IgE)-mediated histamine release. We have examined whether cAMP-active agents inhibit the cytosolic Ca2+, [Ca2+](i), response that normally accompanies activation of basophils. As previously described, this [Ca2+](i) response is biphasic, one phase dependent on internal sources of calcium and a second later phase dependent on extracellular calcium, as observed in many cell types. Forskolin and rolipram or their combination had no effect on the initial elevation of cytosolic calcium that follows stimulation with anti-IgE antibody. In contrast, the second phase of the IgE- mediated calcium response was inhibited by these agents. For IgE-mediated responses, the relative efficacy of various cAMP active agents (rolipram ≃ forskolin 3) receptor or InsP3 metabolism and (2) the mechanisms that maintain the second-phase calcium response are possibly distinct for IgE- and fMLP- mediated reactions because cAMP-active agents inhibited the second-phase response of only one stimulus.",
keywords = "anti-IgE, basophils, calcium, cAMP, fMLP",
author = "Botana, {L. M.} and Donald Macglashan",
year = "1994",
language = "English (US)",
volume = "55",
pages = "798--804",
journal = "Journal of Leukocyte Biology",
issn = "0741-5400",
publisher = "FASEB",
number = "6",

}

TY - JOUR

T1 - Differential effects of cAMP-elevating drugs on stimulus-induced cytosolic calcium changes in human basophils

AU - Botana, L. M.

AU - Macglashan, Donald

PY - 1994

Y1 - 1994

N2 - Drugs that elevate cAMP levels in human basophils are known to inhibit immunoglobulin E (IgE)-mediated histamine release. We have examined whether cAMP-active agents inhibit the cytosolic Ca2+, [Ca2+](i), response that normally accompanies activation of basophils. As previously described, this [Ca2+](i) response is biphasic, one phase dependent on internal sources of calcium and a second later phase dependent on extracellular calcium, as observed in many cell types. Forskolin and rolipram or their combination had no effect on the initial elevation of cytosolic calcium that follows stimulation with anti-IgE antibody. In contrast, the second phase of the IgE- mediated calcium response was inhibited by these agents. For IgE-mediated responses, the relative efficacy of various cAMP active agents (rolipram ≃ forskolin 3) receptor or InsP3 metabolism and (2) the mechanisms that maintain the second-phase calcium response are possibly distinct for IgE- and fMLP- mediated reactions because cAMP-active agents inhibited the second-phase response of only one stimulus.

AB - Drugs that elevate cAMP levels in human basophils are known to inhibit immunoglobulin E (IgE)-mediated histamine release. We have examined whether cAMP-active agents inhibit the cytosolic Ca2+, [Ca2+](i), response that normally accompanies activation of basophils. As previously described, this [Ca2+](i) response is biphasic, one phase dependent on internal sources of calcium and a second later phase dependent on extracellular calcium, as observed in many cell types. Forskolin and rolipram or their combination had no effect on the initial elevation of cytosolic calcium that follows stimulation with anti-IgE antibody. In contrast, the second phase of the IgE- mediated calcium response was inhibited by these agents. For IgE-mediated responses, the relative efficacy of various cAMP active agents (rolipram ≃ forskolin 3) receptor or InsP3 metabolism and (2) the mechanisms that maintain the second-phase calcium response are possibly distinct for IgE- and fMLP- mediated reactions because cAMP-active agents inhibited the second-phase response of only one stimulus.

KW - anti-IgE

KW - basophils

KW - calcium

KW - cAMP

KW - fMLP

UR - http://www.scopus.com/inward/record.url?scp=0028304773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028304773&partnerID=8YFLogxK

M3 - Article

C2 - 7515096

AN - SCOPUS:0028304773

VL - 55

SP - 798

EP - 804

JO - Journal of Leukocyte Biology

JF - Journal of Leukocyte Biology

SN - 0741-5400

IS - 6

ER -